Our CMO, Dr. Steve Shrewsbury, will be presenting the latest information on our THOR201 clinical study in Parkinson’s disease at the World Parkinson’s Congress in Kyoto, Japan. For more information, visit the event page here.

The Impel team is attending the American Society of Clinical Psychopharmacology 2019 annual meeting in Scottsdale, AZ. Jasna Hocevar-Trnka, M.D., M.P.H., will be presenting a talk on the results of our SNAP101 clinical study for INP105 (acute agitation). She will…

The Impel team is attending the American Psychiatric Association 2019 annual meeting in San Francisco, CA and will be presenting data on our first clinical study for our INP105 POD-Olanzapine program. For more information, visit the event page here.